Mostrando 10 resultados de: 27
Filtros aplicados
Publisher
American Journal of Therapeutics(10)
Current Pharmaceutical Design(3)
Revista Latinoamericana de Hipertension(3)
Vessel Plus(3)
Current Hypertension Reports(2)
Área temáticas
Enfermedades(22)
Farmacología y terapéutica(8)
Salud y seguridad personal(5)
Medicina y salud(3)
Alimentación y bebidas(1)
Association between apoliprotein E gene polymorphism and hypercholesterolemic phenotype in maracaibo, Zulia State, Venezuela
ArticleAbstract: Apoliprotein (Apo) E gene polymorphisms have been associated with high plasma lipids levels and cardPalabras claves:ApoE, Cardiovascular disease, hypercholesterolemia, Lipids profile, polymorphismsAutores:Arráiz N., Carem Prieto, Escalona C., Reyes F., Rondón N., Sánchez M.P., Sanz E., Valmore Bermúdez, Velasco M.Fuentes:scopusBiochemical and clinical characterization of metabolic phenotypes: A cross-sectional study from Maracaibo city, Venezuela
ArticleAbstract: Background: In 1980, Reuben Andresen observed that in certain individuals, obesity did not increasePalabras claves:Coronary risk, Metabolic phenotypes, Metabolically healthyobese, Metabolically unhealthy lean, Two-step clusterAutores:Añez-Ramos R., Calvo M.J., Cerda M., Garicano C.M.D., Graterol M., Graterol R., Hernández J.D., Martínez M.S., Mindiola A., Olivar L.C., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M., Wilches-Duran S.Fuentes:scopusBiologic Behavior and optimal cut-off point estimation for Serum Fasting Insulin: A report from the Maracaibo City Metabolic Syndrome Prevalence Study
ArticleAbstract: Introduction: Insulin resistance is a metabolic state in which tissue effects of insulin are diminisPalabras claves:Cut-off point, hyperinsulinemia, Insulin, Insulin Resistance, Metabolic syndromeAutores:Amell A., Arráiz N., Calvo M.J., Carem Prieto, Chávez C., Chávez-Castillo M., David A., Escalona C., Gómez M.C., Lubo A., Martínez M.S., Mengual-Moreno E., Rojas-Quintero J., Romero J., Salazar-Vílchez J., Toledo A., Valero P., Valmore Bermúdez, Velasco M.Fuentes:googlescopusAn elevated level of physical activity is associated with normal lipoprotein(a) levels in individuals from Maracaibo, Venezuela
ArticleAbstract: Coronary artery disease is the main cause of death worldwide. Lipoprotein(a) [Lp(a)], is an independPalabras claves:Cardiovascular Risk, Lifestyle, lipoprotein(a), Physical activityAutores:Acosta L., Añez-Ramos R., Aparicio D., Arráiz N., Cano R.A., Cano-Ponce C., Colmenares C., Faria J., Finol F., Mengual-Moreno E., Peñaranda L., Pineda C., Rodriguez D., Rojas E.R., Rojas-Quintero J., Sanchez W., Sorell L.T., Toledo A.C., Urribarí J., Valmore Bermúdez, Velasco M.Fuentes:scopusAnti-aging effect of metformin: A molecular and therapeutical perspective
ReviewAbstract: Aging is a time-dependent inevitable process, in which cellular homeostasis is affected, which has aPalabras claves:ageing, Anti-ageing drugs, Geronto-protective properties, Metformin, Type 2 Diabetes mellitusAutores:Cano-Ponce C., D’marco L., Galbán N., Gomez Y., González M.C., Herazo Y., Morillo V., Nava M., Rojas M., Rojas-Quintero J., Torres W., Valmore Bermúdez, Velasco M.Fuentes:scopusAMPK as target for intervention in childhood and adolescent obesity
ReviewAbstract: Childhood obesity is a major worldwide health problem. Intervention programs to ameliorate the ratePalabras claves:Autores:Aguirre M.A., Arráiz N., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusEnergetic metabolism in cardiomyocytes: molecular basis of heart ischemia and arrhythmogenesis
ReviewAbstract: Cardiac muscle contraction is a strictly regulated process which conjugates a series of electrophysiPalabras claves:Arrhythmias, cardiomyocyte, ischemia, myocardial infarction, Myocardial metabolismAutores:Chávez-Castillo M., García A., Luzardo E., Martínez M.S., Olivar L.C., Quintero J.J.R., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusErratum: Energetic metabolism in Cardiomyocytes: Molecular basis of heart ischemia and arrhythmogenesis (Vessel Plus (2017) 1 (230-241) DOI: 10.20517/2574-1209.2017.34)
OtherAbstract: The original article was published on 28 Dec 2017. After the publication of the article named “EnergPalabras claves:Autores:Chávez-Castillo M., García A., Luzardo E., Martínez M.S., Olivar L.C., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusEffect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects
ArticleAbstract: Dopamine agonists play an important role in the regulation of the central nervous-cardiovascular, rePalabras claves:dopamine, Dopaminergic agonists, Dopaminergic receptors, Hypertension, Insulin, Type 2 Diabetes mellitusAutores:Bolívar H., Cano R.A., Contreras F., Foullioux C., Lares M., Leal E.M., Maroun C., Pacheco B., Valmore Bermúdez, Velasco M.Fuentes:scopusEffects of metoclopramide and metoclopramide/dopamine on blood pressure and insulin release in normotensive, hypertensive, and type 2 diabetic subjects
ArticleAbstract: The objective is to determine cardiovascular and insulin release effects under metoclopramide (MTC)Palabras claves:dopamine, Dopamine receptors, Hypertension, Insulin release, Metoclopramide, Type 2 DiabetesAutores:Bolívar H., Cano R.A., Contreras F., Fouillioux C., González M.C., Hernández-Hernandez R., Lares M., Valmore Bermúdez, Velasco M.Fuentes:scopus